Skip to main content

Table 2 Comparison of adverse clinical events before NEC onset between the two groups

From: Clinical characterization of necrotizing enterocolitis in neonates with or without congenital heart disease: a case–control study

 

nCHD-NEC group

(n = 120)

CHD-NEC group

(n = 60)

Statistical values

P value

Premature rupture of membranes (n, %)

32(26.7%)

2(3.3%)

11.03

0.002

PDA (n, %)

32(26.7%)

44(73.3%)

19.30

< 0.001

Age at onset (days)

14.5(12.75,20.75)

14(9,21)

0.09

0.765

Circulatory shock (n, %)

44(36.7%)

49(81.7%)

18.23

< 0.001

 Distributive shock

44(36.7%)

16(26.7%)

0.95

0.329

 cardiogenic shock

8(6.7%)

38(63.3%)

26.01

< 0.001

 obstructive shock

0

15(25%)

9.00

0.003

 Mixed shock

8(6.7%)

16(26.7%)

5.00

0.025

Vasoactive inotropic score

0(0,10)

16.75(7.26,23.63)

17.46

< 0.001

Feeding (n, %)

    

 breast milk

4(3.3%)

0(%)

2.02

0.333

 Formula

92(76.7%)

60(100%)

15.18

< 0.001

 Mixed feeding

24(20%)

0(0%)

12.86

< 0.001

RBC transfusion (n, %)

96(80.0%)

49(81.7%)

0.04

1.000

Number of erythrocyte transfusions

2(2,4)

1(1,1.25)

26.46

< 0.001

Infusion of red blood cells 48 h before onset (n, %)

73(60.8%)

37(61.7%)

0.24

0.943

Mechanical ventilation (n, %)

62(51.7%)

55(91.7%)

20.09

< 0.001

Early onset sepsis (n, %)

28(23.3%)

4(6.7%)

5.18

0.038

Late onset sepsis (n,% )

84(70.0%)

28(46.7%)

4.39

0.036

Umbilical vein catheterization (n, %)

8(6.7%)

0(0%)

4.09

0.109

  1. Note. Continuous data are presented as median (interquartile range). Categorical data are presented as counts (%). PDA, patent ductus arteriosus; RBC, red blood cell